The current study advances the field by demonstrating that Ac-SDKP has an anti-fibrotic effect on silicosis in vivo and in vitro, an effect that involves inhibition of TGF-β induced myofibroblast differentiation, leading to a decrease in SRF, α-SMA and ECM deposition. Here, SRF is linked to silicosis.